Company / Cash & Equivalents
Prestige Consumer Healthcare Cash & Equivalents History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$97.9M
FY2025
5-year range
$27.2M / $97.9M
FY2021-FY2025
Trend
+110.6%
vs FY2024
Sector context
#143 of 207
Health Care
What the data says
At $98M, Prestige Consumer Healthcare's cash & equivalents ranks #143 of 207 in the Health Care sector. Cash & Equivalents has fluctuated over the past 9 years, ranging from $27M in FY2022 to $98M in FY2025.
Based on SEC 10-K filings.
$98M in FY2025 with a 5-year CAGR of +0.7%.
Improved from $58M to $98M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +53.3%
- 5-Year CAGR
- +0.7%
- 10-Year CAGR
- -
Sector benchmark
#143 of 207 in Health CareTop 69% of 207This company $97.9M Sector average $669.5M
▼
-85.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.7%, indicating consistent growth.
- In FY2025, cash & equivalents increased 110.6% year-over-year.
- Ranks #143 out of 207 companies in the Health Care sector.
- Lowest cash & equivalents in the period was in FY2022.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | $97.9M | +110.6% |
| FY2024 | $46.5M | -20.6% |
| FY2023 | $58.5M | +115.2% |
| FY2022 | $27.2M | -15.8% |
| FY2021 | $32.3M | -65.9% |
| FY2020 | $94.8M | +244.2% |
| FY2019 | $27.5M | -34.2% |
| FY2018 | $41.9M | +0.0% |
| FY2017 | $41.9M | +53.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026